MedPath

VALEANT PHARMACEUTICALS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Phase 2
Conditions
Acne Vulgaris
Interventions
Drug: IDP-120 Gel
Drug: IDP-120 Component A
Drug: IDP-120 Component B
Drug: IDP-120 Vehicle Gel
First Posted Date
2015-09-01
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
350
Registration Number
NCT02537483

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Phase 3
Conditions
Acne Vulgaris
Interventions
Drug: IDP-121 Vehicle Lotion
First Posted Date
2015-08-31
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
800
Registration Number
NCT02535871

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Phase 2
Conditions
Acne Vulgaris
Interventions
Drug: Vehicle Cream
Drug: Vehicle Lotion
First Posted Date
2015-08-17
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
210
Registration Number
NCT02525822

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Phase 3
Conditions
Acne Vulgaris
Interventions
Drug: IDP-121 Vehicle Lotion
First Posted Date
2015-07-07
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
800
Registration Number
NCT02491060

Thermage CPT for Treatment of Facial and Neck Laxity

Not Applicable
Completed
Conditions
Skin Aging
Interventions
Device: Thermage CPT
First Posted Date
2013-02-05
Last Posted Date
2017-06-09
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
50
Registration Number
NCT01783496
Locations
🇺🇸

Solta Medical Aesthetic Center, Hayward, California, United States

© Copyright 2025. All Rights Reserved by MedPath